GeneticTesting.com
News & Insights

Genetic testing industry news

Funding rounds, product launches, research findings, and policy updates — published 3× per week.

Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine FoundationIndustry

Genomic Sovereignty in MENA: How the Region Is Building Its Own Precision Medicine Foundation

MENA nations are investing in homegrown genomic infrastructure to reduce dependence on Western datasets and drive regional precision medicine.

2026-10-12

Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics ExpansionIndustry

Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Southeast Asian Genomics Expansion

Gene Solutions is pursuing a Hong Kong IPO to accelerate its genomic testing expansion across Southeast Asia's fast-growing healthcare markets.

2026-10-11

NeoGenomics FDA-Approved PTEN Test Raises the Question: Is the Stock Undervalued?Product

NeoGenomics FDA-Approved PTEN Test Raises the Question: Is the Stock Undervalued?

NeoGenomics launches its FDA-approved PTEN companion diagnostic test, prompting analysts to revisit whether NEO shares are underpriced.

2026-10-10

Current Genetic Testing in Cancer May Miss Most Inherited Gene Variants, Study WarnsResearch

Current Genetic Testing in Cancer May Miss Most Inherited Gene Variants, Study Warns

Standard cancer genetic testing protocols may fail to detect the majority of inherited gene variants, raising urgent questions about clinical completeness.

2026-10-09

Advanced DNA Testing Identifies 1983 Homicide Victim, Showcasing Forensic Genomics' Cold Case PowerIndustry

Advanced DNA Testing Identifies 1983 Homicide Victim, Showcasing Forensic Genomics' Cold Case Power

Advanced DNA analysis has identified a homicide victim more than four decades after the 1983 crime, demonstrating forensic genomics' growing reach.

2026-10-08

Arboretum Launches as a Next-Generation Molecular Information Company Targeting Precision Medicine for Common DiseasesIndustry

Arboretum Launches as a Next-Generation Molecular Information Company Targeting Precision Medicine for Common Diseases

Arboretum launches to bring precision medicine's molecular depth to common diseases, positioning itself as a next-gen molecular information company.

2026-10-07

A Better Understanding of Fetal DNA Could Improve Prenatal Testing AccuracyResearch

A Better Understanding of Fetal DNA Could Improve Prenatal Testing Accuracy

New research into fetal DNA biology may sharpen the accuracy and reliability of non-invasive prenatal genetic testing.

2026-10-06

Whole Genome Sequencing Diagnoses 47% of Pediatric Neurological Cases, Reshaping the Rare Disease WorkupResearch

Whole Genome Sequencing Diagnoses 47% of Pediatric Neurological Cases, Reshaping the Rare Disease Workup

Whole genome sequencing achieved a 47% diagnostic yield in pediatric neurological cases, signaling a paradigm shift in rare disease medicine.

2026-10-05

Tempus AI Wins FDA Approval for Tumor-Only xT CDx, Consolidating Its Solid Tumor Genomic PortfolioProduct

Tempus AI Wins FDA Approval for Tumor-Only xT CDx, Consolidating Its Solid Tumor Genomic Portfolio

Tempus AI's tumor-only xT CDx gains FDA approval, allowing full migration of its DNA solid tumor portfolio to a single companion diagnostic.

2026-10-04

BioNTech Veterans Land $25M Seed Round to Build Virtual Cancer Surveillance PlatformFunding

BioNTech Veterans Land $25M Seed Round to Build Virtual Cancer Surveillance Platform

Former BioNTech scientists secured $25M in seed funding to develop a virtual cancer surveillance startup focused on early detection.

2026-10-03

GenePlanet Secures Strategic Investment from Lauxera, Sets Sights on Unicorn StatusFunding

GenePlanet Secures Strategic Investment from Lauxera, Sets Sights on Unicorn Status

Slovenia's GenePlanet lands strategic investment from Lauxera Capital, fueling ambitions to become a billion-dollar genomics company.

2026-10-02

Arkansas Becomes Third U.S. State to Deploy Rapid DNA Testing at Booking StationsPolicy

Arkansas Becomes Third U.S. State to Deploy Rapid DNA Testing at Booking Stations

Saline County, Arkansas, goes live with Rapid DNA technology at its jail, marking a significant expansion of forensic genomics in law enforcement.

2026-10-01

DNA Test Cracks the Code on Inherited Muscle Disease, Offering New Answers for Patients Left Without DiagnosesResearch

DNA Test Cracks the Code on Inherited Muscle Disease, Offering New Answers for Patients Left Without Diagnoses

A new DNA test is successfully identifying the genetic causes of inherited muscle disease in patients who previously had no diagnosis.

2026-09-30

Regeneron Wins FDA Approval for First Neurosensory Gene Therapy, Opening a New Frontier in Genetic MedicineProduct

Regeneron Wins FDA Approval for First Neurosensory Gene Therapy, Opening a New Frontier in Genetic Medicine

Regeneron has secured FDA approval for the first neurosensory gene therapy, marking a landmark moment for the genetic medicine field.

2026-09-29

Singapore's National Precision Medicine Program Charts a Path From Genomic Data to Clinical RealityResearch

Singapore's National Precision Medicine Program Charts a Path From Genomic Data to Clinical Reality

Singapore's NPM program publishes findings on translating large-scale genomic data into actionable healthcare practice across diverse Asian populations.

2026-09-28

Guardant Health's FDA-Cleared Genomic-Epigenomic Liquid Biopsy Panel Signals a New Era in Cancer DetectionProduct

Guardant Health's FDA-Cleared Genomic-Epigenomic Liquid Biopsy Panel Signals a New Era in Cancer Detection

FDA clears Guardant360 Liquid CDx, the largest approved liquid biopsy panel, combining genomic and epigenomic analysis in a single test.

2026-09-27

BGI Genomics Partner Géntodos Opens Mexico Lab, Staking a Claim in Latin America's Precision Medicine MarketIndustry

BGI Genomics Partner Géntodos Opens Mexico Lab, Staking a Claim in Latin America's Precision Medicine Market

BGI Genomics strategic partner Géntodos has inaugurated a new laboratory in Mexico, establishing a precision medicine hub for Latin America.

2026-09-26

NeoGenomics Launches FDA-Approved PTEN Test, Raising Questions About ValuationProduct

NeoGenomics Launches FDA-Approved PTEN Test, Raising Questions About Valuation

NeoGenomics launches an FDA-approved PTEN diagnostic test, prompting analysts to reassess whether the oncology genomics company is currently undervalued.

2026-09-25

Proteins Emerge as a Promising New Layer in Forensic Science's Genetic ToolkitResearch

Proteins Emerge as a Promising New Layer in Forensic Science's Genetic Toolkit

Proteomics is gaining ground as a forensic identification tool, potentially complementing DNA analysis in cases where genetic material degrades.

2026-09-24

Mayo Clinic Laboratories Makes Strategic Investments in Pathology Asia Holdings and LifeStrands GenomicsIndustry

Mayo Clinic Laboratories Makes Strategic Investments in Pathology Asia Holdings and LifeStrands Genomics

Mayo Clinic Laboratories invests in two Asia-Pacific diagnostics firms to accelerate precision medicine and genomics capabilities across the region.

2026-09-23

Circular Genomics and Altoida Partner to Build Multimodal Precision Medicine Platform for Alzheimer's DiseaseResearch

Circular Genomics and Altoida Partner to Build Multimodal Precision Medicine Platform for Alzheimer's Disease

Circular Genomics and Altoida are collaborating to develop the first multimodal precision medicine approach targeting Alzheimer's disease.

2026-09-22

Precure Selects Helix as Multi-Omics Lab and AI Tools Provider in Landmark PartnershipIndustry

Precure Selects Helix as Multi-Omics Lab and AI Tools Provider in Landmark Partnership

Precure, LLC has chosen Helix as its multi-omics laboratory and AI tools provider, signaling growing demand for integrated genomic platforms.

2026-09-21

Uganda's NFSU Deploys Rapid DNA Technology to Transform Criminal Investigation CapabilitiesIndustry

Uganda's NFSU Deploys Rapid DNA Technology to Transform Criminal Investigation Capabilities

Uganda's National Forensic Science University unveils Rapid DNA technology to accelerate criminal investigations and strengthen forensic genomics infrastructure.

2026-09-20

Stanford Scientists Are Rethinking Genome Sequencing to Unlock Precision Medicine's Next ChapterResearch

Stanford Scientists Are Rethinking Genome Sequencing to Unlock Precision Medicine's Next Chapter

Stanford Medicine researchers are reconsidering foundational approaches to genome sequencing to better translate genomic data into clinical precision medicine.

2026-09-19

AI and Genomics Converge to Redefine What Precision Medicine Can DeliverResearch

AI and Genomics Converge to Redefine What Precision Medicine Can Deliver

AI-genomics integration is reshaping precision medicine pipelines, expanding diagnostic depth and accelerating clinical decision-making across oncology and beyond.

2026-09-18

Tempus AI Wins FDA Approval for Tumor-Only Genomic Test, Expanding Oncology AccessProduct

Tempus AI Wins FDA Approval for Tumor-Only Genomic Test, Expanding Oncology Access

Tempus AI receives FDA approval for a tumor-only genomic test, broadening clinical genomics access for oncology patients without matched normal samples.

2026-09-17

AGBT Names 2026 Precision Health Next Gen Leadership Award RecipientsIndustry

AGBT Names 2026 Precision Health Next Gen Leadership Award Recipients

AGBT has announced its 2026 Precision Health Next Gen Leadership Award recipients, spotlighting emerging talent driving genomics innovation.

2026-09-16

Gene Solutions Eyes Hong Kong IPO to Finance Next Phase of Genomics ExpansionFunding

Gene Solutions Eyes Hong Kong IPO to Finance Next Phase of Genomics Expansion

Vietnam's Gene Solutions is pursuing a Hong Kong IPO to fund its international expansion across the genetic testing and genomics sector.

2026-09-15

Vietnam Moves to Address Regulatory and Ethical Gaps in DNA Testing DeploymentPolicy

Vietnam Moves to Address Regulatory and Ethical Gaps in DNA Testing Deployment

Vietnam flags three critical issues in DNA testing deployment as genomic technology expands rapidly across the country.

2026-09-14

Regeneron's FDA-Approved Neurosensory Gene Therapy Marks a Turning Point for Rare Disease GenomicsProduct

Regeneron's FDA-Approved Neurosensory Gene Therapy Marks a Turning Point for Rare Disease Genomics

Regeneron wins FDA approval for the first-ever neurosensory gene therapy, opening a new chapter in genomic medicine for rare sensory disorders.

2026-09-13

Guardant Health's Expanded Liquid Biopsy Panel Earns FDA Clearance with 100x Footprint GrowthProduct

Guardant Health's Expanded Liquid Biopsy Panel Earns FDA Clearance with 100x Footprint Growth

FDA approves new Guardant360 Liquid CDx, the largest cleared liquid biopsy panel, combining genomic and epigenomic profiling in one test.

2026-09-12

Slovenia's GenePlanet Secures Strategic Investment from Lauxera in Unicorn-Backed Genomics PushFunding

Slovenia's GenePlanet Secures Strategic Investment from Lauxera in Unicorn-Backed Genomics Push

GenePlanet lands strategic investment from Lauxera, positioning the Slovenian genomics firm as a credible unicorn candidate in European precision health.

2026-09-11

Prostate Cancer Genomic Analysis Links Mutational Footprints to Clinical OutcomesResearch

Prostate Cancer Genomic Analysis Links Mutational Footprints to Clinical Outcomes

New genomic analysis of prostate cancer ties mutational signatures directly to clinical outcomes, advancing precision oncology strategies.

2026-09-10

At-Home DNA Tests: What They Can and Can't Tell You About Inherited Health RisksIndustry

At-Home DNA Tests: What They Can and Can't Tell You About Inherited Health Risks

Consumer DNA tests are growing in popularity, but clinicians warn they offer an incomplete picture of inherited disease risk.

2026-09-09

Carla Walker Act Targets Cold Case DNA Funding Gap as Forensic Genomics Gains Legislative MomentumPolicy

Carla Walker Act Targets Cold Case DNA Funding Gap as Forensic Genomics Gains Legislative Momentum

New federal legislation aims to expand DNA technology funding for cold case investigations, boosting forensic genomics capabilities nationwide.

2026-09-08

Roche Korea Recognized for Advancing Cancer Precision Medicine as Oncogenomics Gains Regional MomentumIndustry

Roche Korea Recognized for Advancing Cancer Precision Medicine as Oncogenomics Gains Regional Momentum

Roche Korea receives KSMO recognition for contributions to cancer precision medicine, highlighting genomics-driven oncology's growing footprint in Asia.

2026-09-07

Guardant Health Jumps 25% After FDA Clears First Genomic-Epigenomic Liquid Biopsy PanelProduct

Guardant Health Jumps 25% After FDA Clears First Genomic-Epigenomic Liquid Biopsy Panel

FDA clearance of Guardant's first genomic-epigenomic liquid biopsy panel sent shares surging 25%, marking a milestone for oncology diagnostics.

2026-09-06

Singapore's National Precision Medicine Program Charts a Path from Genomic Data to Clinical PracticeResearch

Singapore's National Precision Medicine Program Charts a Path from Genomic Data to Clinical Practice

Singapore's NPM program publishes findings on translating large-scale genomic data into real-world healthcare practice, advancing precision medicine.

2026-09-05

BioNTech Veterans Secure $25M Seed Round to Build AI-Powered Cancer Surveillance PlatformFunding

BioNTech Veterans Secure $25M Seed Round to Build AI-Powered Cancer Surveillance Platform

Former BioNTech scientists raise $25M to develop a virtual cancer surveillance startup targeting early detection and monitoring.

2026-09-04

Stanford Scientists Rethink Genome Sequencing Frameworks to Strengthen Precision MedicineResearch

Stanford Scientists Rethink Genome Sequencing Frameworks to Strengthen Precision Medicine

Stanford Medicine researchers are reconsidering foundational approaches to genome sequencing to make precision medicine more clinically actionable.

2026-09-03

Mount Sinai Launches Center for Genomic AI and Microbiome Medicine to Advance Precision CareResearch

Mount Sinai Launches Center for Genomic AI and Microbiome Medicine to Advance Precision Care

Mount Sinai's new center combines genomic AI and microbiome medicine to push precision diagnostics and treatment into clinical practice.

2026-09-02

Whole Exome Sequencing Market Headed for $10.24 Billion as Clinical Demand AcceleratesIndustry

Whole Exome Sequencing Market Headed for $10.24 Billion as Clinical Demand Accelerates

The whole exome sequencing market is on track to reach $10.24 billion, driven by surging clinical adoption and precision medicine integration.

2026-09-01

Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Regional Genomics ExpansionFunding

Vietnam's Gene Solutions Eyes Hong Kong IPO to Fund Regional Genomics Expansion

Gene Solutions, Vietnam's leading genomics company, is pursuing a Hong Kong IPO to finance its expansion across Southeast Asia.

2026-08-31

NIH's All of Us Program Hits Precision Medicine Milestone, Reshaping the Genomics Research LandscapeResearch

NIH's All of Us Program Hits Precision Medicine Milestone, Reshaping the Genomics Research Landscape

The All of Us Research Program has reached a major milestone, expanding one of the world's most diverse genomic datasets for precision medicine.

2026-08-30

Regeneron's First Neurosensory Gene Therapy Approval Signals a New Era for Genetic MedicineProduct

Regeneron's First Neurosensory Gene Therapy Approval Signals a New Era for Genetic Medicine

Regeneron wins FDA approval for the first neurosensory gene therapy, marking a landmark moment for genetic treatment beyond rare metabolic disease.

2026-08-29

Genetic Testing Market Projected to Surge Past $62 Billion by 2035 as Clinical Adoption DeepensIndustry

Genetic Testing Market Projected to Surge Past $62 Billion by 2035 as Clinical Adoption Deepens

The global genetic testing market is forecast to reach $62.61 billion by 2035, driven by oncology, prenatal, and precision medicine demand.

2026-08-28

ICE Moves to Expand Rapid DNA Testing for Family Verification at the BorderPolicy

ICE Moves to Expand Rapid DNA Testing for Family Verification at the Border

ICE is seeking to broaden its use of rapid DNA testing to verify familial relationships, raising technical and civil liberties questions.

2026-08-27

GenePlanet Secures Strategic Investment from Lauxera in Bid to Become Genomics UnicornFunding

GenePlanet Secures Strategic Investment from Lauxera in Bid to Become Genomics Unicorn

Slovenia's GenePlanet has landed a strategic investment from Lauxera, setting its sights on unicorn status in the consumer and clinical genomics market.

2026-08-26

Cell-Free DNA Testing Market Targets 2034 as Clinical Adoption Accelerates Across Oncology and Prenatal CareIndustry

Cell-Free DNA Testing Market Targets 2034 as Clinical Adoption Accelerates Across Oncology and Prenatal Care

The cell-free DNA testing market is on a sustained growth trajectory toward 2034, driven by expanding clinical applications and improving technology.

2026-08-25

Next-Generation Sequencing in Precision Medicine Market Poised to Reach $14.05 BillionIndustry

Next-Generation Sequencing in Precision Medicine Market Poised to Reach $14.05 Billion

The NGS in precision medicine market is on track to hit $14.05 billion, signaling sustained institutional investment in genomic diagnostics.

2026-08-24

Guardant360 Liquid CDx Expansion Redraws the Boundaries of Liquid Biopsy TestingProduct

Guardant360 Liquid CDx Expansion Redraws the Boundaries of Liquid Biopsy Testing

FDA approves an expanded Guardant360 Liquid CDx panel, making it the largest FDA-approved liquid biopsy panel available.

2026-08-23

Certain Lung Cancer Biomarkers Slip Through DNA-Only Testing, Study WarnsResearch

Certain Lung Cancer Biomarkers Slip Through DNA-Only Testing, Study Warns

New findings show DNA-based tests may miss key lung cancer biomarkers, raising questions about the adequacy of single-modality genomic profiling.

2026-08-06

Datar Cancer Genetics Wins FDA Clearance for Dual DNA+RNA Comprehensive Genomic Profiling AssayProduct

Datar Cancer Genetics Wins FDA Clearance for Dual DNA+RNA Comprehensive Genomic Profiling Assay

Datar Cancer Genetics receives FDA clearance for CellDx-Tissue, a comprehensive genomic profiling assay for solid tumors using both DNA and RNA.

2026-08-05

Precision Medicine Needs More Precise Diagnostics to Fulfill Its Clinical PromiseResearch

Precision Medicine Needs More Precise Diagnostics to Fulfill Its Clinical Promise

Experts argue that advances in precision medicine are being bottlenecked by diagnostics that can't yet match therapeutic specificity.

2026-08-04

Single-Cell Multiomics Market Projected to Reach $18.20 Billion by 2035 as Technology MaturesIndustry

Single-Cell Multiomics Market Projected to Reach $18.20 Billion by 2035 as Technology Matures

The single-cell multiomics market is forecast to hit $18.20B by 2035, signaling accelerating adoption across clinical and research genomics.

2026-08-03

David Sinclair Startup Raises $80M to Bring Anti-Aging Gene Therapy into Clinical TrialsFunding

David Sinclair Startup Raises $80M to Bring Anti-Aging Gene Therapy into Clinical Trials

A startup co-founded by longevity researcher David Sinclair has raised $80M to fund a clinical trial of an anti-aging gene therapy.

2026-08-02

Large Genomic Atlas Maps How Pregnancy Reshapes Maternal Biology at the Molecular LevelResearch

Large Genomic Atlas Maps How Pregnancy Reshapes Maternal Biology at the Molecular Level

A large-scale genomic atlas reveals how pregnancy fundamentally alters maternal biology, with major implications for precision medicine and prenatal care.

2026-08-01

Gene Solutions Eyes Hong Kong IPO as Southeast Asian Genomics Market Heats UpIndustry

Gene Solutions Eyes Hong Kong IPO as Southeast Asian Genomics Market Heats Up

Vietnam's Gene Solutions is pursuing a Hong Kong IPO to finance regional expansion, signaling growing investor appetite for Asian genomics.

2026-07-31

Singapore's National Precision Medicine Program Demonstrates How Genomic Data Translates into Real Clinical PracticeResearch

Singapore's National Precision Medicine Program Demonstrates How Genomic Data Translates into Real Clinical Practice

Singapore's National Precision Medicine program publishes findings on translating large-scale genomic data into actionable healthcare practice.

2026-07-30

Germany's Precision Medicine Pilot Moves from Blueprint to Reality with Data Infrastructure Now in PlaceIndustry

Germany's Precision Medicine Pilot Moves from Blueprint to Reality with Data Infrastructure Now in Place

Germany's national precision medicine pilot has cleared its foundational data infrastructure hurdle, signaling a new phase of clinical genomics at scale.

2026-07-29

Regeneron's FDA-Approved Neurosensory Gene Therapy Marks a Turning Point for Genetic MedicineProduct

Regeneron's FDA-Approved Neurosensory Gene Therapy Marks a Turning Point for Genetic Medicine

Regeneron has won FDA approval for the first neurosensory gene therapy, expanding the clinical frontier of genetic medicine into hearing and sensory disorders.

2026-07-28

Ethical Challenges in Genome Sequencing and Precision Medicine Demand Industry-Wide ReckoningResearch

Ethical Challenges in Genome Sequencing and Precision Medicine Demand Industry-Wide Reckoning

Genomics leaders are confronting mounting ethical questions around genome sequencing and precision medicine as clinical adoption accelerates globally.

2026-07-27

Blended Genome–Exome Sequencing Cuts Costs Without Sacrificing Diagnostic QualityResearch

Blended Genome–Exome Sequencing Cuts Costs Without Sacrificing Diagnostic Quality

A blended genome–exome sequencing approach delivers equivalent diagnostic accuracy at meaningfully lower cost, new research shows.

2026-07-26

Hillsborough County Closes Three Cold Cases with Advanced DNA TechnologyIndustry

Hillsborough County Closes Three Cold Cases with Advanced DNA Technology

Three decades-old cold cases in Hillsborough County have been solved using modern DNA technology, underscoring forensic genomics' growing investigative power.

2026-07-25

Suspect Identified in 31-Year-Old Cold Case Murder Using DNA Technology: A Testament to Forensic GenomicsIndustry

Suspect Identified in 31-Year-Old Cold Case Murder Using DNA Technology: A Testament to Forensic Genomics

DNA technology has identified a suspect in the 31-year-old murder of a young mother, underscoring forensic genomics' growing power to resolve cold cases.

2026-07-24

Guardant Health's Expanded Liquid Biopsy Panel Redraws the Boundaries of Advanced Cancer TestingProduct

Guardant Health's Expanded Liquid Biopsy Panel Redraws the Boundaries of Advanced Cancer Testing

FDA approves new Guardant360 Liquid CDx with a 100x expanded genomic footprint, setting a new benchmark for liquid biopsy panels.

2026-07-23

Graduate Student's Precision Medicine Research Targets Genomic Equity Gap in Underserved CommunitiesResearch

Graduate Student's Precision Medicine Research Targets Genomic Equity Gap in Underserved Communities

A St. Mary's University graduate student is leveraging medical genomics to broaden access to precision medicine in underrepresented populations.

2026-07-22

Instruments of Self-Knowledge: What Your Genome Can — and Can't — Tell You About YourselfIndustry

Instruments of Self-Knowledge: What Your Genome Can — and Can't — Tell You About Yourself

Direct-to-consumer genetic testing turned DNA from an abstract concept into something a person can read for themselves. What that means depends entirely on how the reading is offered.

2026-07-21

Vietnam Accelerates Next-Generation DNA Testing to Identify Fallen Soldiers from Past ConflictsResearch

Vietnam Accelerates Next-Generation DNA Testing to Identify Fallen Soldiers from Past Conflicts

Vietnam is deploying next-generation DNA sequencing technology to identify the remains of soldiers lost in historical conflicts.

2026-07-21

Michigan Legislation Spotlights DNA Evidence as a Cornerstone of Wrongful Conviction ReformPolicy

Michigan Legislation Spotlights DNA Evidence as a Cornerstone of Wrongful Conviction Reform

New Michigan bills aim to lower barriers to overturning wrongful convictions, with DNA testing emerging as a central evidentiary mechanism.

2026-07-20

Silicon Valley's Push to Genetically Engineer Babies Forces a Reckoning for the Genomics IndustryPolicy

Silicon Valley's Push to Genetically Engineer Babies Forces a Reckoning for the Genomics Industry

Tech investors are funding efforts to produce genetically engineered babies despite global bans, raising urgent questions for clinical genomics.

2026-07-19

DNA Technology Opens New Pathways for Foster Youth Seeking Biological Family ConnectionsResearch

DNA Technology Opens New Pathways for Foster Youth Seeking Biological Family Connections

DNA testing tools are being applied to help foster youth locate biological relatives, expanding the humanitarian reach of consumer genomics platforms.

2026-07-18

Precision Psychiatry Challenges Genomics as the Primary Lens for Mental Health TreatmentResearch

Precision Psychiatry Challenges Genomics as the Primary Lens for Mental Health Treatment

Neuroscientist Amit Etkin argues brain activity biomarkers, not genomics, will define the future of precision psychiatry.

2026-07-17

AccurEdit Raises $75M to Advance Gene Editing Therapies Showing Early Clinical PromiseFunding

AccurEdit Raises $75M to Advance Gene Editing Therapies Showing Early Clinical Promise

China-based AccurEdit has secured $75M to develop gene editing therapies demonstrating encouraging early-stage results.

2026-07-16

Gene Solutions Eyes Hong Kong IPO to Fuel Southeast Asian Genomics ExpansionFunding

Gene Solutions Eyes Hong Kong IPO to Fuel Southeast Asian Genomics Expansion

Vietnam's Gene Solutions is pursuing a Hong Kong IPO to finance its regional expansion across Southeast Asia's fast-growing genomics market.

2026-07-15

Regeneron Wins FDA Approval for First Neurosensory Gene Therapy, Marking a Genomic Medicine MilestoneProduct

Regeneron Wins FDA Approval for First Neurosensory Gene Therapy, Marking a Genomic Medicine Milestone

Regeneron has received FDA approval for the first neurosensory gene therapy, a landmark moment for genomic medicine and rare disease treatment.

2026-07-14

AI in Genomics Market Poised to Reach $9.32 Billion by 2030 as Precision Medicine Accelerates AdoptionIndustry

AI in Genomics Market Poised to Reach $9.32 Billion by 2030 as Precision Medicine Accelerates Adoption

The AI in genomics market is projected to hit $9.32 billion by 2030, driven by surging demand for precision medicine applications worldwide.

2026-07-13

Blended Genome–Exome Sequencing Cuts Costs Without Sacrificing Data QualityResearch

Blended Genome–Exome Sequencing Cuts Costs Without Sacrificing Data Quality

A blended genome–exome sequencing approach delivers cost savings over standard methods while maintaining diagnostic-grade data quality.

2026-07-12

NIH's All of Us Program Becomes World's Largest Integrated Genomics and Health DatabaseResearch

NIH's All of Us Program Becomes World's Largest Integrated Genomics and Health Database

The All of Us Research Program has surpassed all rivals to claim the title of the world's largest integrated genomics and health database.

2026-07-11

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate CancerProduct

NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer

NeoGenomics debuts an FDA-approved PTEN IHC companion diagnostic, expanding precision oncology options for prostate cancer patients.

2026-07-10

Guardant Health's Guardant360 Liquid CDx Earns FDA Approval with 100x Expanded Panel FootprintProduct

Guardant Health's Guardant360 Liquid CDx Earns FDA Approval with 100x Expanded Panel Footprint

FDA approves the new Guardant360 Liquid CDx as the largest FDA-approved liquid biopsy panel, dramatically expanding its genomic coverage.

2026-07-08

DNA Diagnostics Market Projected to Hit $24.7 Billion by 2034 as Precision Medicine Drives Global DemandIndustry

DNA Diagnostics Market Projected to Hit $24.7 Billion by 2034 as Precision Medicine Drives Global Demand

The global DNA diagnostics market is forecast to reach $24.7B by 2034, fueled by precision medicine adoption and rapid genomic advancements.

2026-07-07

Illumina Receives FDA Clearance for Next-Generation Sequencing Panel Targeting Rare Pediatric DisordersProduct

Illumina Receives FDA Clearance for Next-Generation Sequencing Panel Targeting Rare Pediatric Disorders

Illumina's TruSight Rare Pediatric panel earns FDA clearance, enabling faster whole-exome-equivalent diagnostics for children with undiagnosed conditions.

2026-06-29

Invitae Spinout Aris Genomics Closes $142M Series B to Scale Pharmacogenomics PlatformFunding

Invitae Spinout Aris Genomics Closes $142M Series B to Scale Pharmacogenomics Platform

Aris Genomics secures $142M Series B to expand its pharmacogenomics platform targeting medication optimization in health systems.

2026-06-26

Illumina Wins FDA Breakthrough Device Designation for Pan-Cancer cfDNA AssayProduct

Illumina Wins FDA Breakthrough Device Designation for Pan-Cancer cfDNA Assay

Illumina's TruSight Oncology Liquid 500 assay receives FDA Breakthrough Device Designation, accelerating its path to clinical market.

2026-06-24

GRAIL's Galleri Multi-Cancer Early Detection Test Advances Toward Broader Medicare CoverageIndustry

GRAIL's Galleri Multi-Cancer Early Detection Test Advances Toward Broader Medicare Coverage

GRAIL's Galleri blood test, which screens for over 50 cancer types from a single blood draw, is advancing through a pivotal Medicare coverage pathway that could make it available to millions.

2026-06-23

Sponsored content

Reach genetic testing decision-makers with your story

Sponsored articles appear in the News feed and the weekly newsletter. $500/article.

Learn more →